Quick Answer
Vicarious Surgical Inc. reported Operating Income Loss of -$50.03 million for the year ending 2025.
- Vicarious Surgical Inc. showed an increase of +24.8% in Operating Income Loss from 2024 to 2025.
- This data is from Vicarious Surgical Inc.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: -$26.7 thousand | Q3 2020: -$3.34 million | Q1 2021: -$5.23 million | Q2 2021: -$6.61 million | Q3 2021: -$8.56 million | Q1 2022: -$18.18 million | Q2 2022: -$19.13 million | Q3 2022: -$22.16 million | Q1 2023: -$22.32 million | Q2 2023: -$21.46 million | Q3 2023: -$21.35 million | Q1 2024: -$16.11 million | Q2 2024: -$17.71 million | Q3 2024: -$17.76 million | Q1 2025: -$15.75 million | Q2 2025: -$13.52 million | Q3 2025: -$11.50 million.
- Over the full 6 years of available data (2020 to 2025), Vicarious Surgical Inc.'s Operating Income Loss has declined by 285.3%.
- Historical annual values: Fiscal year 2025: -$50.03 million | Fiscal year 2024: -$66.56 million | Fiscal year 2023: -$80.67 million | Fiscal year 2022: -$80.08 million | Fiscal year 2021: -$38.22 million | Fiscal year 2020: -$12.99 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: